Pangaea Oncology SA (id:4789 PANG)

1.75 EUR

Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:16:15 PM)

Exchange open, closes in 13 minutes

• 1 week
• 1 month
• 6 months
• 1 year
• 5 years
• All

About Pangaea Oncology SA

Market Capitalization 58.26M

Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development. Pangaea Oncology, S.A. was founded in 2006 and is based in Barcelona, Spain.